Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions
After primary treatment, biochemical relapse (BCR) occurs in a substantial number of patients with prostate cancer (PCa). PET/CT imaging with prostate-specific membrane antigen based tracers (68Ga-PSMA) has shown promising results for BCR patients. However, a standardized image interpretation method...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
September 2017
|
| In: |
European journal of nuclear medicine and molecular imaging
Year: 2017, Volume: 44, Issue: 10, Pages: 1622-1635 |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-017-3725-1 |
| Online Access: | Resolving-System, Volltext: http://dx.doi.org/10.1007/s00259-017-3725-1 Verlag, Volltext: https://link.springer.com/article/10.1007%2Fs00259-017-3725-1 
|
| Author Notes: | Stefano Fanti, Silvia Minozzi, Joshua James Morigi, Frederik Giesel, Francesco Ceci, Christian Uprimny, Michael S. Hofman, Matthias Eiber, Sarah Schwarzenbock, Paolo Castellucci, Cristina Bellisario, Stéphane Chauvie, Fabrizio Bergesio, Louise Emmett, Uwe Haberkorn, Irene Virgolini, Markus Schwaiger, Rodney J. Hicks, Bernd J. Krause, Arturo Chiti |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1583979417 | ||
| 003 | DE-627 | ||
| 005 | 20230427161325.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181122s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00259-017-3725-1 |2 doi | |
| 035 | |a (DE-627)1583979417 | ||
| 035 | |a (DE-576)513979417 | ||
| 035 | |a (DE-599)BSZ513979417 | ||
| 035 | |a (OCoLC)1341024135 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Fanti, Stefano |d 1964- |e VerfasserIn |0 (DE-588)136800882 |0 (DE-627)615227368 |0 (DE-576)314191984 |4 aut | |
| 245 | 1 | 0 | |a Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions |c Stefano Fanti, Silvia Minozzi, Joshua James Morigi, Frederik Giesel, Francesco Ceci, Christian Uprimny, Michael S. Hofman, Matthias Eiber, Sarah Schwarzenbock, Paolo Castellucci, Cristina Bellisario, Stéphane Chauvie, Fabrizio Bergesio, Louise Emmett, Uwe Haberkorn, Irene Virgolini, Markus Schwaiger, Rodney J. Hicks, Bernd J. Krause, Arturo Chiti |
| 264 | 1 | |c September 2017 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 22.11.2018 | ||
| 520 | |a After primary treatment, biochemical relapse (BCR) occurs in a substantial number of patients with prostate cancer (PCa). PET/CT imaging with prostate-specific membrane antigen based tracers (68Ga-PSMA) has shown promising results for BCR patients. However, a standardized image interpretation methodology has yet to be properly agreed. The aim of this study, which was promoted and funded by European Association of Nuclear Medicine (EANM), is to define standardized image interpretation criteria for 68Ga-PSMA PET/CT to detect recurrent PCa lesions in patients treated with primary curative intent therapy (radical prostatectomy or radiotherapy) who presented a biochemical recurrence. | ||
| 650 | 4 | |a Biochemical recurrence | |
| 650 | 4 | |a Consensus guidelines | |
| 650 | 4 | |a Criteria | |
| 650 | 4 | |a Pet/Ct | |
| 650 | 4 | |a Prostate cancer | |
| 650 | 4 | |a PSMA | |
| 700 | 1 | |a Giesel, Frederik L. |d 1970- |e VerfasserIn |0 (DE-588)129031240 |0 (DE-627)387883878 |0 (DE-576)297457071 |4 aut | |
| 700 | 1 | |a Haberkorn, Uwe |d 1959- |e VerfasserIn |0 (DE-588)1022913905 |0 (DE-627)717331245 |0 (DE-576)366166352 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of nuclear medicine and molecular imaging |d Heidelberg [u.a.] : Springer-Verl., 2002 |g 44(2017), 10, Seite 1622-1635 |h Online-Ressource |w (DE-627)359787258 |w (DE-600)2098375-X |w (DE-576)110279549 |x 1619-7089 |7 nnas |a Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions |
| 773 | 1 | 8 | |g volume:44 |g year:2017 |g number:10 |g pages:1622-1635 |g extent:14 |a Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00259-017-3725-1 |x Resolving-System |x Verlag |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007%2Fs00259-017-3725-1 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181122 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1022913905 |a Haberkorn, Uwe |m 1022913905:Haberkorn, Uwe |d 910000 |d 911400 |e 910000PH1022913905 |e 911400PH1022913905 |k 0/910000/ |k 1/910000/911400/ |p 15 | ||
| 998 | |g 129031240 |a Giesel, Frederik L. |m 129031240:Giesel, Frederik L. |d 910000 |d 911400 |e 910000PG129031240 |e 911400PG129031240 |k 0/910000/ |k 1/910000/911400/ |p 4 | ||
| 999 | |a KXP-PPN1583979417 |e 3032933404 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"recId":"359787258","title":[{"title_sort":"European journal of nuclear medicine and molecular imaging","subtitle":"official journal of the European Association of Nuclear Medicine (EANM)","title":"European journal of nuclear medicine and molecular imaging"}],"id":{"zdb":["2098375-X"],"eki":["359787258"],"issn":["1619-7089"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisher":"Springer-Verl.","dateIssuedDisp":"2002-","dateIssuedKey":"2002","publisherPlace":"Heidelberg [u.a.]"}],"language":["eng"],"part":{"year":"2017","volume":"44","issue":"10","pages":"1622-1635","extent":"14","text":"44(2017), 10, Seite 1622-1635"},"note":["Gesehen am 13.02.2023","Ungezählte Beil.: Supplement"],"pubHistory":["29.2002 -"],"disp":"Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesionsEuropean journal of nuclear medicine and molecular imaging","type":{"bibl":"periodical","media":"Online-Ressource"}}],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"September 2017"}],"title":[{"title_sort":"Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions","title":"Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"14 S."}],"id":{"eki":["1583979417"],"doi":["10.1007/s00259-017-3725-1"]},"recId":"1583979417","person":[{"role":"aut","family":"Fanti","display":"Fanti, Stefano","given":"Stefano"},{"role":"aut","family":"Giesel","given":"Frederik L.","display":"Giesel, Frederik L."},{"family":"Haberkorn","role":"aut","display":"Haberkorn, Uwe","given":"Uwe"}],"note":["Gesehen am 22.11.2018"],"language":["eng"],"name":{"displayForm":["Stefano Fanti, Silvia Minozzi, Joshua James Morigi, Frederik Giesel, Francesco Ceci, Christian Uprimny, Michael S. Hofman, Matthias Eiber, Sarah Schwarzenbock, Paolo Castellucci, Cristina Bellisario, Stéphane Chauvie, Fabrizio Bergesio, Louise Emmett, Uwe Haberkorn, Irene Virgolini, Markus Schwaiger, Rodney J. Hicks, Bernd J. Krause, Arturo Chiti"]}} | ||
| SRT | |a FANTISTEFADEVELOPMEN2017 | ||